Zimmer Biomet Holdings ROE 2006-2019 | ZBH

Current and historical return on equity (ROE) values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Zimmer Biomet Holdings ROE for the three months ending June 30, 2019 was 13.40%.
Zimmer Biomet Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $-0.36B $11.66B -3.07%
2019-03-31 $-0.31B $11.54B -2.62%
2018-12-31 $-0.38B $11.28B -3.19%
2018-09-30 $1.75B $12.22B 14.61%
2018-06-30 $1.69B $12.04B 14.62%
2018-03-31 $1.69B $12.00B 15.19%
2017-12-31 $1.81B $11.74B 17.10%
2017-09-30 $0.65B $10.45B 6.47%
2017-06-30 $0.71B $10.28B 7.19%
2017-03-31 $0.50B $9.93B 5.11%
2016-12-31 $0.31B $9.67B 3.18%
2016-09-30 $0.36B $9.75B 3.75%
2016-06-30 $0.23B $9.55B 2.32%
2016-03-31 $0.08B $9.66B 0.85%
2015-12-31 $0.15B $9.89B 1.60%
2015-09-30 $0.17B $9.99B 2.02%
2015-06-30 $0.32B $10.13B 4.28%
2015-03-31 $0.67B $6.58B 10.26%
2014-12-31 $0.72B $6.55B 11.19%
2014-09-30 $0.83B $6.54B 12.96%
2014-06-30 $0.81B $6.45B 12.86%
2014-03-31 $0.78B $6.24B 12.75%
2013-12-31 $0.78B $6.30B 12.98%
2013-09-30 $0.68B $6.14B 11.49%
2013-06-30 $0.70B $5.89B 12.05%
2013-03-31 $0.77B $5.71B 13.23%
2012-12-31 $0.76B $5.87B 13.11%
2012-09-30 $0.76B $5.83B 13.38%
2012-06-30 $0.77B $5.71B 13.76%
2012-03-31 $0.76B $5.66B 13.38%
2011-12-31 $0.76B $5.52B 13.25%
2011-09-30 $0.64B $5.61B 11.01%
2011-06-30 $0.64B $6.02B 10.89%
2011-03-31 $0.60B $5.86B 10.37%
2010-12-31 $0.60B $5.77B 10.36%
2010-09-30 $0.72B $5.82B 12.52%
2010-06-30 $0.68B $5.74B 11.72%
2010-03-31 $0.72B $5.71B 12.45%
2009-12-31 $0.72B $5.64B 12.48%
2009-09-30 $0.73B $5.98B 12.70%
2009-06-30 $0.80B $5.81B 14.05%
2009-03-31 $0.81B $5.56B 14.54%
2008-12-31 $0.85B $5.65B 15.10%
2008-09-30 $0.95B $5.62B 16.96%
2008-06-30 $0.78B $5.51B 14.15%
2008-03-31 $0.78B $5.71B 14.38%
2007-12-31 $0.77B $5.45B 14.67%
2007-09-30 $0.76B $5.25B 14.68%
2007-06-30 $0.89B $5.28B 17.75%
2007-03-31 $0.86B $5.12B 17.47%
2006-12-31 $0.84B $4.92B 17.09%
2006-09-30 $0.79B $4.80B 16.37%
2006-06-30 $0.78B $4.90B 16.33%
2006-03-31 $0.77B $4.92B 16.64%
2005-12-31 $0.73B $4.68B 16.64%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $28.674B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $148.939B 20.91
Abbott Laboratories (ABT) United States $147.101B 27.65
Stryker (SYK) United States $82.696B 28.60
Boston Scientific (BSX) United States $59.981B 29.09
Baxter (BAX) United States $44.653B 27.08
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.863B 0.00
Coloplast (CLPBY) Denmark $25.834B 41.24
Terumo (TRUMY) Japan $23.226B 26.71
Smith & Nephew SNATS (SNN) United Kingdom $20.906B 0.00
ResMed (RMD) United States $19.182B 36.58
Sunny Optical Technology (SNPTF) China $16.804B 0.00
Bio-Rad Laboratories (BIO) United States $10.124B 54.27
Insulet (PODD) United States $9.197B 544.96
Canopy Growth (CGC) Canada $9.163B 0.00
Perrigo (PRGO) Ireland $7.388B 13.61
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.984B 20.82
Haemonetics (HAE) United States $6.525B 49.24
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.265B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.167B 0.00
Neogen (NEOG) United States $4.002B 66.44
NuVasive (NUVA) United States $3.387B 27.00
ICU Medical (ICUI) United States $3.307B 21.45
Hutchison China MediTech (HCM) China $2.719B 0.00
Quidel (QDEL) United States $2.651B 26.33
Agios Pharmaceuticals (AGIO) United States $2.117B 0.00
National Vision Holdings (EYE) United States $2.015B 43.49
Cardiovascular Systems (CSII) United States $1.761B 0.00
Aphria (APHA) $1.519B 0.00
VAREX IMAGING (VREX) United States $1.090B 25.12
AtriCure (ATRC) United States $1.008B 0.00
Lantheus Holdings (LNTH) United States $1.003B 26.37
Omeros (OMER) United States $0.896B 0.00
Phibro Animal Health (PAHC) United States $0.881B 14.34
Eagle Pharmaceuticals (EGRX) United States $0.802B 20.45
NanoString Technologies (NSTG) United States $0.801B 0.00
Cerus (CERS) United States $0.745B 0.00
PetIQ (PETQ) United States $0.730B 17.25
LeMaitre Vascular (LMAT) United States $0.709B 42.01
MacroGenics (MGNX) United States $0.636B 0.00
Surmodics (SRDX) United States $0.620B 117.92
TG Therapeutics (TGTX) United States $0.607B 0.00
Quanterix (QTRX) United States $0.599B 0.00
OraSure Technologies (OSUR) United States $0.462B 21.40
Meridian Bioscience (VIVO) United States $0.407B 12.71
BioLife Solutions (BLFS) United States $0.396B 130.13
Utah Medical Products (UTMD) United States $0.368B 26.98
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.351B 0.00
Owens & Minor (OMI) United States $0.349B 10.47
Zynex (ZYXI) United States $0.315B 33.45
United Health Products (UEEC) United States $0.270B 0.00
Bovie Medical (APYX) United States $0.247B 0.00
Rockwell Medical (RMTI) United States $0.207B 0.00
Cytosorbents (CTSO) United States $0.178B 0.00
Vapotherm (VAPO) United States $0.174B 0.00
Chimerix (CMRX) United States $0.143B 0.00
Fonar (FONR) United States $0.142B 10.11
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Female Health (VERU) United States $0.122B 0.00
United-Guardian (UG) United States $0.085B 20.07
Nephros (NEPH) United States $0.068B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.027B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00